Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.00 | 22.71 |
| PEG Ratio (TTM) | 0.04 | 0.12 |
| P/S Ratio (TTM) | N/A | 3.05 |
| P/B Ratio (TTM) | 1.53 | 1.55 |
| P/FCF Ratio (TTM) | -21.55 | 36.77 |
| Price to 5YR AVG Earnings Ratio | N/A | 40.75 |
| Price to 5YR AVG FCF Ratio | N/A | 45.07 |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 9.87% | 10.91% |
| ROE (TTM) | 27.10% | -11.33% |
| Net Profit Margin (TTM) | N/A | 12.36% |
| ROIC 5YR AVG | N/A | 22.21% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -2,891.36% | N/A | N/A |
| Revenue | N/A | N/A | N/A |
| Net Income | -6,183.80% | N/A | N/A |
| Cash Flow | -3,031.03% | N/A | N/A |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 7.46 | 1.58 |
| Quick Ratio (TTM) | 7.46 | 1.10 |
| D/E Ratio (TTM) | N/A | -0.34 |
| Interest Coverage (TTM) | N/A | 13.51 |
| Piotroski F-Score | 4 | 7 |
| Altman Z-Score | 1.62 | 5.15 |
| LTL to 5YR AVG FCF | N/A | 6.77 |
| Shares Outstanding Growth 5YR AVG | N/A | -0.67% |